Saturday, October 31, 2015

Coming Soon to a Psychiatrist's Office Near You?

Take a look at a video clip that really should be called awesome...

Using extraordinary analytic tools available today, future psychiatrists will be able to offer diagnostic and treatment services that will revive and give new meaning to the field of psychoanalysis.  Some of this technology is currently being used to create brain to machine interfaces that permit the restoration of function to seriously disabled patients.  

From mentally moving cursors on computer screens by comatose patients, to understanding human cognitive and emotional experience, the future reads more like science fiction than science fact.

That is, if the currently disabled world political system can waken from its collective coma and provide the will and financing to permit human evolution to return to a focus on evolving.

Friday, October 30, 2015

Penetrating the Blood-Brain Barrier: New Frontier in Drug Delivery Strategies

Brain "Window" To Permit Pharmaceutical Access via Nasal Spray


Drug Delivery across Blood-Brain Barrier
Drugs used to treat a variety of central nervous system diseases may be administered through the nose and diffused through an implanted mucosal graft (A, in red) to gain access to the brain. Under normal circumstances, there are multiple layers within the nose that block the access of pharmaceutical agents from getting to the brain including bone and the dura/arachnoid membrane, which represents part of the blood-brain barrier (B). After endoscopic skull base surgery (C), all of these layers are removed and replaced with a nasal mucosal graft, which is 1,000 times more porous than the native blood-brain barrier. Consequently, these grafts may be used to deliver very large drugs, including proteins, which would otherwise be blocked by the blood-brain barrier. 
Credit: Garyfallia Pagonis and Benjamin S. Bleier, M.D.

Wednesday, October 28, 2015

More Data Supporting Oxytocin Nasal Spray

http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2015162a.html

The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical cross-over trial

Abstract

Interventions for autism are limited. The synthetic hormone oxytocin may provide a potential treatment to improve core social and behavioral difficulties in autism, but its efficacy has yet to be evaluated in young children who potentially may benefit to a greater extent. We investigated the efficacy, tolerability and safety of oxytocin treatment in young children with autism using a double-blind, randomized, placebo-controlled, crossover, clinical trial. Thirty-one children with autism received 12 International Units (IU) of oxytocin and placebo nasal spray morning and night (24IU per day) for 5 weeks, with a 4-week washout period between each treatment. Compared with placebo, oxytocin led to significant improvements on the primary outcome of caregiver-rated social responsiveness. Overall, nasal spray was well tolerated, and the most common reported adverse events were thirst, urination and constipation. This study is the first clinical trial to support the potential of oxytocin as an early intervention for young children with autism to help improve social interaction deficits.

Monday, October 19, 2015

Look Up Between the Swan and the Lyre: Is Someone Watching Us?

Are these the evidence of intelligent life out there?

http://www.theatlantic.com/science/archive/2015/10/the-most-interesting-star-in-our-galaxy/410023/

Monday, October 5, 2015

Human Brains May Deal with Moment-to-Moment Emotional Awareness via Quantum Cognition

The human brain as a probability statement generator may rely on this model to avoid the fear of the reality that it may not exist in the next moment.  Moment-to-moment emotional awareness requires the "courage" to continue to take that risk while permitting our feelings to become conscious without "freaking out."  A theory of Quantum Cognition may provide a reasonable explanation of how we do that:

  • Highlights
  • Quantum cognition models are founded on principles drawn from quantum physics.
  • Quantum models parsimoniously address puzzling cognitive phenomena.
  • Standard probabilistic models and quantum models are contrasted and compared.

What type of probability theory best describes the way humans make judgments under uncertainty and decisions under conflict? Although rational models of cognition have become prominent and have achieved much success, they adhere to the laws of classical probability theory despite the fact that human reasoning does not always conform to these laws. For this reason we have seen the recent emergence of models based on an alternative probabilistic framework drawn from quantum theory. These quantum models show promise in addressing cognitive phenomena that have proven recalcitrant to modeling by means of classical probability theory. This review compares and contrasts probabilistic models based on Bayesian or classical versus quantum principles, and highlights the advantages and disadvantages of each approach.





Wednesday, September 30, 2015

Mind Games: First Demonstration of Non-Invasive Human Brain-to-Brain Communication

Playing 20 Questions with the Mind: Collaborative Problem Solving by Humans Using a Brain-to-Brain Interface



We present, to our knowledge, the first demonstration that a non-invasive brain-to-brain interface (BBI) can be used to allow one human to guess what is on the mind of another human through an interactive question-and-answering paradigm similar to the “20 Questions” game. As in previous non-invasive BBI studies in humans, our interface uses electroencephalography (EEG) to detect specific patterns of brain activity from one participant (the “respondent”), and transcranial magnetic stimulation (TMS) to deliver functionally-relevant information to the brain of a second participant (the “inquirer”). Our results extend previous BBI research by (1) using stimulation of the visual cortex to convey visual stimuli that are privately experienced and consciously perceived by the inquirer; (2) exploiting real-time rather than off-line communication of information from one brain to another; and (3) employing an interactive task, in which the inquirer and respondent must exchange information bi-directionally to collaboratively solve the task. The results demonstrate that using the BBI, ten participants (five inquirer-respondent pairs) can successfully identify a “mystery item” using a true/false question-answering protocol similar to the “20 Questions” game, with high levels of accuracy that are significantly greater than a control condition in which participants were connected through a sham BBI.

Sunday, March 15, 2015

Washington Post Tabloid Journalism Challenged by Doctors

http://www.washingtonpost.com/news/to-your-health/wp/2015/02/24/lay-off-the-mega-doses-of-vitamin-d/

Physicians responding to an article sensationalizing criticism of prescribing large doses of vitamin D to correct inadequate serum levels take on the media giant.  Read the article and the comments section for an example of doctors calling out tabloid journalism designed to "frighten an already terrified citizenry."

Friday, March 13, 2015

Drug Restores Memory in Early Alzheimer's Disease

http://dgnews.docguide.com/drug-restores-brain-function-memory-early-alzheimers-disease?overlay=2&nl_ref=newsletter&pk_campaign=newsletter

Drug Restores Memory in Early Alzheimer's Disease

BALTIMORE, Md -- March 11, 2015 -- A novel therapeutic approach for an existing drug reverses a condition in elderly patients who are at high risk for dementia due to Alzheimer's disease, according to a study published this week in NeuroImage: Clinical.
Levetiracetam, commonly used to treat epilepsy, calms hyperactivity in the brain of patients with amnestic mild cognitive impairment (aMCI).
Hippocampal over-activity is well-documented in patients with aMCI and its occurrence predicts further cognitive decline and progression to Alzheimer's dementia.
“What we've shown is that very low doses of the atypical antiepileptic levetiracetam reduces this over-activity,” said Michela Gallagher, MD, Johns Hopkins University, Baltimore, Maryland. “At the same time, it improves memory performance on a task that depends on the hippocampus.”
The team studied 84 subjects; 17 of them were normal healthy participants and the rest had symptoms of aMCI. Everyone was aged older than 55 years. Patients were randomised to varying doses of levetiracetam or placebo.
The researchers found that low doses of the drug improved memory performance and normalised the over-activity detected by functional magnetic resonance imaging (fMRI) that measures brain activity during a memory task. 
“What we want to discover now, is whether treatment over a longer time will prevent further cognitive decline and delay or stop progression to Alzheimer's dementia,” said Dr. Gallagher.
SOURCE: Johns Hopkins University
Hippocampal over-activity is well-documented in patients with aMCI and its occurrence predicts further cognitive decline and progression to Alzheimer's dementia.
“What we've shown is that very low doses of the atypical antiepileptic levetiracetam reduces this over-activity,” said Michela Gallagher, MD, Johns Hopkins University, Baltimore, Maryland. “At the same time, it improves memory performance on a task that depends on the hippto varying doses of levetiracetam or placebo.
The researchers found that low doses of the drug improved memory performance and normalised the over-activity detected by functional magnetic resonance imaging (fMRI) that measures brain activity during a memory task. 
“What we want to discover now, is whether treatment over a longer time will prevent further cognitive decline and delay or stop progression to Alzheimer's dementia,” said Dr. Gallagher.
SOURCE: Johns Hopkins University

Sunday, September 7, 2014

Neuroscience of Leaders Who "Work Well With Others"

From my perspective, one of the most troublesome problems of the human species blocking the next evolutionary leap is the apparent reduction in empathy, compassion and the ability to "put oneself in another's shoes."

 During the past decade, the discovery of the "controversial" mirror-neurons in chimps, the potential of non-invasive, magnetic brain  stimulation, and the promise of empathy- enhancing substances such as oxytocin appear to be encouraging breakthroughs.

However, despite these and other physiological advances, the growing stress of living in a dangerously competitive world continues to ignite the flames of fear-based aggression among nations, cultures, races, businesses, families, groups and individuals.

 Moreover, I find it difficult to ignore the willful, self-serving fanning of those flames by powerful governments, industries, politicians and corporations and individuals who profit in many ways from the fear of difference that seems to be rampant on the planet.

 Consequently, my wish for the next advance in brain research would be the development of methods to permit populations to scientifically evaluate the brains of candidates before electing them to powerful positions of authority.

 In such a brave, new world, strength of leadership might include such characteristics as better control of impulsivity, a capacity to tolerate and understand the complexity of reality without false simplifications, better deductive reasoning and higher quality decision-making abilities. And although "even  paranoids may have real enemies," leaders should possess an enhanced capacity for actual empathy and compassion as well as an ability to quickly analyze risk and act decisively when necessary.

And while I'm dreaming, I should recommend development of a Gross National Happiness statistic to be added to the material indices we watch so carefully. It might produce data with which we could really evaluate the  value of our leaders.

Hidden Agendas in American News

More Evidence about the need for skepticism when watching news programs on TV.

  • Suboptimal facial expression primes in textual media messages: Evidence for the affective congruency effect

    Original Research Article
  • Pages 64-77
  • Niklas Ravaja, Jari Kätsyri

    Abstract

    The effectiveness of suboptimal affective primes in real media applications has remained debatable. We investigated the effects of suboptimally (at 10-ms exposure) presented facial expression primes on emotional responses to, and cognitive evaluations of, textual (business news) messages ranging from slightly unpleasant to slightly pleasant among 33 participants. Facial expression primes were presented repeatedly on a simulated small screen of a mobile device during a news reading task. Facial electromyography (EMG) recordings were used as physiological indices of positive and negative emotions. Our results showed affective congruency effects between news messages and facial expression primes: joyful facial expressions, compared to angry primes or no priming, elicited higher positive affect evaluations and more positive facial EMG responses, as well as higher interest, when embedded in affectively more positive news. On the other hand, the mere presence of suboptimal primes was detrimental to the perceived trustworthiness of news. These results suggest that embedding suboptimal facial expression primes into textual media messages may exert an influence on affectively congruent messages; at the same time, our results highlight the potential hazards and difficulties of utilizing such primes.
    Citing articles (0)

Do You Choose Your Thoughts?

NAC

http://www.plosone.org/annotation/listThread.action?root=81739


Increased Coupling of Intrinsic Networks in Remitted Depressed Youth Predicts Rumination and Cognitive Control

Rachel H. Jacobs and 
Lisanne M. Jenkins, et. al.

Published: August 27, 2014DOI: 10.1371/journal.pone.0104366


"The authors have chosen to investigate a common symptom in most individuals who experience depression as well as those who suffer from many other psychiatric conditions.  Moreover, the capacity to choose what one wishes to think about without the mood-changing interruptions of invasive rumination and obsession may be less common than previously considered in many individuals with or without a psychiatric diagnosis.

Anecdotally, my experience with N-Acetyl Cysteine  in psychiatric patients (as well as personal-development clients with rumination and obsession who carry no official psychiatric diagnosis) suggests a potentially significant beneficial effect.  It would appear that the authors have established an evaluation paradigm with which this finding might be tested.

Monday, March 10, 2014

10-Lipid Profile May Identify Future Alzheimer's Patients



Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer’s Disease

  1. 1Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  2. 2Knight Alzheimer’s Disease Research Center at Washington University School of Medicine, St. Louis, MO 63110, USA.
  3. 3Division of Biostatistics, Washington University School of Medicine, St. Louis, MO 63110, USA.
  4. 4Department of Psychiatry, Washington University School of Medicine, St. Louis, MO 63110, USA.
  5. 5Department of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  6. 6Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN 46202, USA.
  7. 7WA Center for Alzheimer’s Research and Care, Edith Cowan University, Perth, Western Australia 6009, Australia.
  8. 8Mental Health Research Institute, University of Melbourne, Melbourne, Victoria 3052, Australia.
  9. 9Department of Neurology, The Taub Institute and the Sergievsky Center, Columbia University, New York, NY 10032, USA.
  10. 10Mary S. Easton Center for Alzheimer’s Disease Research, Department of Neurology, University of California, Los Angeles, Los Angeles, CA 90095, USA.
  11. 11Dementia Research Center, University College London, London WC1N 3BG, UK.
  12. 12Departments of Neurology and Psychiatry, Warren Alpert Medical School of Brown University, Butler Hospital, Providence, RI 02906, USA.
  13. 13Neuroscience Research Australia, Sydney, New South Wales 2031, Australia.
  14. 14School of Medical Sciences, University of New South Wales, Sydney, New South Wales 2031, Australia.
  15. 15Department of Neurology, Brigham and Women’s Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
  16. 16Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  17. 17http://www.dian-info.org/personnel.htm
  1. *Corresponding author. E-mail: fagana@neuro.wustl.edu

Abstract

Clinicopathological evidence suggests that the pathology of Alzheimer’s disease (AD) begins many years before the appearance of cognitive symptoms. Biomarkers are required to identify affected individuals during this asymptomatic (“preclinical”) stage to permit intervention with potential disease-modifying therapies designed to preserve normal brain function. Studies of families with autosomal-dominant AD (ADAD) mutations provide a unique and powerful means to investigate AD biomarker changes during the asymptomatic period. In this biomarker study, we collected cerebrospinal fluid (CSF), plasma, and in vivo amyloid imaging cross-sectional data at baseline in individuals from ADAD families enrolled in the Dominantly Inherited Alzheimer Network. Our study revealed reduced concentrations of CSF amyloid-β1–42 (Aβ1–42) associated with the presence of Aβ plaques, and elevated concentrations of CSF tau, ptau181 (phosphorylated tau181), and VILIP-1 (visinin-like protein-1), markers of neurofibrillary tangles and neuronal injury/death, in asymptomatic mutation carriers 10 to 20 years before their estimated age at symptom onset (EAO) and before the detection of cognitive deficits. When compared longitudinally, however, the concentrations of CSF biomarkers of neuronal injury/death within individuals decreased after their EAO, suggesting a slowing of acute neurodegenerative processes with symptomatic disease progression. These results emphasize the importance of longitudinal, within-person assessment when modeling biomarker trajectories across the course of the disease. If corroborated, this pattern may influence the definition of a positive neurodegenerative biomarker outcome in clinical trials.

Tuesday, March 4, 2014

But, It's Only a Dog...?

Feeling Simpatico with Your Dog? It May Be Based on Similar Human–Canine Brain Structures

New research shows that humans and dogs have very similar voice-sensitive brain regions, which may help explain our intense bonds with these furry, four-legged friends
Dog lies motionless in a MRI brain scanner


A dog lies motionless in an fMRI brain scanner at the MR Research Center in Budapest.
Credit: Flickr/Eniko Kubinyi
You may snicker when you see dog owners talk to their pets as though they were human or view YouTube videos of dogs supposedly speaking English back to their owners, saying words like “banana” and “I love you.” And with good reason: although dogs have the capacity to understand more than 100 words, studies have demonstrated Fido can’t really speak human languages or comprehend them with the same complexity that we do. Yet researchers have now discovered that dog and human brains process the vocalizations and emotions of others more similarly than previously thought. The findings suggest that although dogs cannot discuss relativity theory with us, they do seem to be wired in a way that helps them to grasp what we feel by attending to the sounds we make.

To compare active human and dog brains, postdoctoral researcher Attila Andics and his team from MTA-ELTE Comparative Ethology Research Group in Hungary trained 11 dogs to lie still in an fMRI brain scanner for several six minute intervals so that the researchers could perform the same experiment on both human and canine participants. Both groups listened to almost two hundred dog and human sounds—from whining and crying to laughter and playful barking—while the team scanned their brain activity.

The resulting study, published in Current Biology today, reveals both that dog brains have voice-sensitive regions and that these neurological areas resemble those of humans. Sharing similar locations in both species, they process voices and emotions of other individuals similarly. Both groups respond with greater neural activity when they listen to voices reflecting positive emotions such as laughing than to negative sounds that include crying or whining. Dogs and people, however, respond more strongly to the sounds made by their own species. “Dogs and humans meet in a very similar social environment but we didn’t know before just how similar the brain mechanisms are to process this social information,” Andics says.

These striking similarities help clarify the timeline and stages of mammalian evolutionary history. Until now researchers had identified voice-sensitive brain regions only in humans and macaque monkeys, whose last common ancestor lived 30 million years ago. The last common ancestor of humans and dogs—a mammalian carnivore with a brain the size of an egg—existed around 100 million years ago. The canine finding thus suggests that the voice-sensitive brain regions in both species evolved at least that long ago, if not earlier. Other mammals on the same evolutionary branch as humans and hounds that also arose from that last mutual ancestor likely share the same brain areas as well.

But dog owners might be most interested in what this study says about our special relationship with canine pets. Humans domesticated dogs somewhere between 18,000 and 32,000 years ago, and since then they have become people’s best friends, hunting partners, guards and even purse accessories. Andics thinks the parallel brain sensitivity to voices and emotions may account in part for our unique bond. “This similarity helps explain what makes vocal communication between dogs and humans so successful,” he says. “It’s why dogs can tune into their owners’ feelings so well.”

Turns out, people who talk to their poodles or golden retrievers aren’t so silly after all.

Monday, January 20, 2014

Consciousness As Part of the Cosmos



An excellent review and discussion of one of the most exciting and controversial theories of Consciousness.

Consciousness in the universe: A review of the ‘Orch OR’ theory

  • a Anesthesiology, Psychology and Center for Consciousness Studies, The University of Arizona, Tucson, AZ, USA
  • b Mathematical Institute and Wadham College, University of Oxford, Oxford, UK

Abstract

The nature of consciousness, the mechanism by which it occurs in the brain, and its ultimate place in the universe are unknown. We proposed in the mid 1990ʼs that consciousness depends on biologically ‘orchestrated’ coherent quantum processes in collections of microtubules within brain neurons, that these quantum processes correlate with, and regulate, neuronal synaptic and membrane activity, and that the continuous Schrödinger evolution of each such process terminates in accordance with the specific Diósi–Penrose (DP) scheme of ‘objective reduction’ (‘OR’) of the quantum state. This orchestrated OR activity (‘Orch OR’) is taken to result in moments of conscious awareness and/or choice. The DP form of OR is related to the fundamentals of quantum mechanics and space–time geometry, so Orch OR suggests that there is a connection between the brainʼs biomolecular processes and the basic structure of the universe. Here we review Orch OR in light of criticisms and developments in quantum biology, neuroscience, physics and cosmology. We also introduce a novel suggestion of ‘beat frequencies’ of faster microtubule vibrations as a possible source of the observed electro-encephalographic (‘EEG’) correlates of consciousness. We conclude that consciousness plays an intrinsic role in the universe.

Highlights

The Orch OR theory proposes quantum computations in brain microtubules account for consciousness.
Microtubule ‘quantum channels’ in which anesthetics erase consciousness are identified.
Evidence for warm quantum vibrations in brain microtubules is cited.
Interference of microtubule vibrations are ‘beat frequencies’ seen as EEG.
Orch OR links consciousness to processes in fundamental space–time geometry.